Literature DB >> 14746881

Increased dopamine transporter density in the male rat brain following chronic nandrolone decanoate administration.

Anna M S Kindlundh1, Sadia Rahman, Jonas Lindblom, Fred Nyberg.   

Abstract

Adolescent males currently employ anabolic-androgenic steroids (AAS) to become intoxicated, besides the traditional desires of an improved physical appearance and enhanced sports performance. Several studies indicate that AAS affect the brain reward system. Recently chronic administration with nandrolone decanoate to male rats has been shown to increase the dopamine transporter (DAT) density in the striatum visualised in vivo by positron emission tomography. The present study aimed to investigate if the increased DAT density could be confirmed using in vitro autoradiography following a comparable regimen of nandrolone treatment. Specific binding of 50 pM [125I] RTI-55 in the presence of 1 microM citalopram was used to label DAT. Two weeks of nandrolone decanoate administration at the supra-therapeutic doses 1, 5 and 15 mg/kg per day increased DAT density in the caudate putamen at all three doses. In conclusion, this study confirms that chronic nandrolone administration increases dopamine transporter density in the CPU and therefore supports the theory that AAS affects the dopamine system in the male rat brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746881     DOI: 10.1016/j.neulet.2003.11.040

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

2.  Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid.

Authors:  Pedro P Pereira-Junior; Elen A Chaves; Ricardo H Costa-E-Sousa; Masako O Masuda; Antonio C Campos de Carvalho; José H M Nascimento
Journal:  Eur J Appl Physiol       Date:  2005-12-13       Impact factor: 3.078

Review 3.  Androgenic anabolic steroid exposure during adolescence: ramifications for brain development and behavior.

Authors:  Rebecca L Cunningham; Augustus R Lumia; Marilyn Y McGinnis
Journal:  Horm Behav       Date:  2012-12-26       Impact factor: 3.587

4.  Subchronic nandrolone administration reduces cocaine-induced dopamine and 5-hydroxytryptamine outflow in the rat nucleus accumbens.

Authors:  Sanna Kurling-Kailanto; Aino Kankaanpää; Timo Seppälä
Journal:  Psychopharmacology (Berl)       Date:  2010-02-26       Impact factor: 4.530

5.  Testosterone is essential for cocaine sensitization in male rats.

Authors:  Raissa Menéndez-Delmestre; Annabell C Segarra
Journal:  Physiol Behav       Date:  2010-10-14

6.  The effect of the anabolic steroid, nandrolone, in conditioned place preference and D1 dopamine receptor expression in adolescent and adult mice.

Authors:  Freddyson J Martínez-Rivera; Eduardo J Natal-Albelo; Namyr A Martínez; Roberto A Orozco-Vega; Oscar A Muñiz-Seda; Jennifer L Barreto-Estrada
Journal:  Behav Processes       Date:  2015-01-20       Impact factor: 1.777

7.  Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats.

Authors:  Li Li; Yun-Xiao Kang; Xiao-Ming Ji; Ying-Kun Li; Shuang-Cheng Li; Xiang-Jian Zhang; Hui-Xian Cui; Ge-Ming Shi
Journal:  CNS Neurosci Ther       Date:  2017-12-06       Impact factor: 5.243

Review 8.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 9.  Anabolic-androgenic steroid dependence: an emerging disorder.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Addiction       Date:  2009-12       Impact factor: 6.526

10.  Testosterone and nucleus accumbens dopamine in the male Syrian hamster.

Authors:  Jennifer L Triemstra; Satoru M Sato; Ruth I Wood
Journal:  Psychoneuroendocrinology       Date:  2008-01-30       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.